D L Emerson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D L Emerson

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Journal of Medicinal Chemistry|February 2, 1996

Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecinK Lackey, D D Sternbach, D K Croom, et al.

Anti-Cancer Drugs|April 6, 2001

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing miceJ P Desjardins, E A Abbott, D L Emerson, et al.

Clinical & Experimental Metastasis|March 1, 1996

Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasisJ G Conway, S J Trexler, J A Wakefield, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Journal of Medicinal Chemistry|February 2, 1996

Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecinK Lackey, D D Sternbach, D K Croom, et al.

Anti-Cancer Drugs|April 6, 2001

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing miceJ P Desjardins, E A Abbott, D L Emerson, et al.

Clinical & Experimental Metastasis|March 1, 1996

Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasisJ G Conway, S J Trexler, J A Wakefield, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.

Pageof 4